Showing results (1-10 of 125) with videos related to
Sort By:
Pageof 13
Molecular Diagnosis & Therapy|June 18, 2014
Molecular biomarkers in interstitial lung diseasesAngelo De Lauretis, Elisabetta A RenzoniRespirology (Carlton, Vic.)|November 30, 2013
Rituximab in severe, treatment-refractory interstitial lung diseaseGregory J Keir, Toby M Maher, Damien Ming, et al.Chronic Respiratory Disease|February 23, 2011
Review series: Aspects of interstitial lung disease: connective tissue disease-associated interstitial lung disease: how does it differ from IPF? How should the clinical approach differ?Angelo de Lauretis, Srihari Veeraraghavan, Elisabetta RenzoniInternational Journal of Rheumatology|September 19, 2012
Circulating biomarkers of interstitial lung disease in systemic sclerosisHarpreet K Lota, Elisabetta A RenzoniMuscle & Nerve|May 30, 2008
Glial fibrillary acidic protein: a marker of axonal Guillain-Barrè syndrome and outcomeFrancesca Notturno, Christina M Caporale, Angelo De Lauretis, et al.American Journal of Respiratory Cell and Molecular Biology|May 8, 2010
Endothelin in pulmonary fibrosisCarmen Fonseca, David Abraham, Elisabetta A RenzoniCurrent Opinion in Immunology|October 14, 2025
Treating sarcoidosis: when less is moreNiamh Logan, Jessica Raja, Elisabetta A RenzoniEuropean Journal of Human Genetics : EJHG|February 25, 2018
Genetic predictors of systemic sclerosis-associated interstitial lung disease: a review of recent literatureCarmel J W Stock, Elisabetta A RenzoniJournal of Clinical Medicine|April 3, 2021
Telomeres in Interstitial Lung DiseaseCarmel J W Stock, Elisabetta A RenzoniLancet (London, England)|September 9, 2021
Disease pathology in fibrotic interstitial lung disease: is it all about usual interstitial pneumonia?Elisabetta A Renzoni, Venerino Poletti, John A MackintoshPageof 13